FARALLON CAPITAL MANAGEMENT LLC - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 110 filers reported holding GOSSAMER BIO INC in Q1 2024. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q1 2024$7,233,721
+29.3%
6,130,2720.0%0.03%
+26.9%
Q4 2023$5,593,873
+9.6%
6,130,2720.0%0.03%
+8.3%
Q3 2023$5,105,291
+210.7%
6,130,272
+2929.9%
0.02%
+242.9%
Q2 2021$1,643,000
+26.4%
202,326
+102.3%
0.01%
-30.0%
Q2 2020$1,300,000
+28.1%
100,0000.0%0.01%
+11.1%
Q1 2020$1,015,000
-87.0%
100,000
-80.0%
0.01%
-83.0%
Q4 2019$7,815,000
+362.2%
500,000
+396.5%
0.05%
+307.7%
Q3 2019$1,691,000
-23.8%
100,712
+0.7%
0.01%
-7.1%
Q2 2019$2,218,000
-72.9%
100,000
-73.5%
0.01%
-77.4%
Q1 2019$8,188,000377,8520.06%
Other shareholders
GOSSAMER BIO INC shareholders Q1 2024
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,758,069$23,085,0006.16%
Ally Bridge Group (NY) LLC 700,000$5,859,0005.34%
Kynam Capital Management, LP 2,350,448$19,673,0005.02%
Omega Fund Management, LLC 1,500,000$12,555,0004.01%
Ikarian Capital, LLC 1,000,387$8,373,0001.53%
HHLR ADVISORS, LTD. 7,420,974$62,114,0001.33%
Boxer Capital, LLC 2,462,358$20,610,0001.30%
Palo Alto Investors LP 1,750,651$14,653,0001.28%
Artal Group S.A. 2,358,968$19,745,0001.06%
Birchview Capital, LP 159,088$1,332,0000.97%
View complete list of GOSSAMER BIO INC shareholders